Publications by authors named "Bijan Nejadnik"

Claim this Profile
M
Modified human mesenchymal stromal/stem cells restore cortical excitability after focal ischemic stroke in rats.
Barbara Klein, Agnieszka Ciesielska, Patricia Morán Losada, Anna Sato, Sajita Shah-Morales, Bijan Nejadnik

Mol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal Stromal Cell Implants for Chronic Motor Deficits After Traumatic Brain Injury: Post Hoc Analysis of a Randomized Trial.
David O Okonkwo, Peter McAllister, Achal S Achrol, Yasuaki Karasawa, Masahito Kawabori, Bijan Nejadnik

Neurology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal Stem Cells Promote an Increase in Neuronal Oscillation via Glutamate Tonic Release.
Ricardo L Azevedo-Pereira, Irina Aizman, Bijan Nejadnik

Neuroscience· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the Minimally Clinically Important Difference for the Disability Rating Scale in Persons With Chronic Traumatic Brain Injury.
Flora M Hammond, Jessica M Ketchum, Vipul Vinod Patni, Bijan Nejadnik, Damien Bates

Neurotrauma Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell therapies for acute and chronic traumatic brain injury.
Masahito Kawabori, Dai Chida, Bijan Nejadnik, Anthony H Stonehouse, David O Okonkwo

Curr Med Res Opin· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury.
Michael A McCrea, Steven C Cramer, David O Okonkwo, Soeren Mattke, Susan Paadre, Bijan Nejadnik

Expert Rev Neurother· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Therapy for Chronic TBI: Interim Analysis of the Randomized Controlled STEMTRA Trial.
Masahito Kawabori, Alan H Weintraub, Hideaki Imai, Iaroslav Zinkevych, Peter McAllister, Bijan Nejadnik

Neurology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of defibrotide in blood and marrow transplantation.
Paul G Richardson, Enric Carreras, Massimo Iacobelli, Bijan Nejadnik

Blood Adv· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
Zhun Cao, Kathleen F Villa, Craig B Lipkin, Scott B Robinson, Bijan Nejadnik

J Med Econ· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Paul G Richardson, Angela R Smith, Brandon M Triplett, Nancy A Kernan, Stephan A Grupp, Bijan Nejadnik

Br J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Paul G Richardson, Angela R Smith, Brandon M Triplett, Nancy A Kernan, Stephan A Grupp, Bijan Nejadnik

Biol Blood Marrow Transplant· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program.
Selim Corbacioglu, Enric Carreras, Mohamad Mohty, Antonio Pagliuca, Jaap Jan Boelens, Bijan Nejadnik

Biol Blood Marrow Transplant· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research.
Christopher Strouse, Paul Richardson, Grant Prentice, Sandra Korman, Robin Hume, Bijan Nejadnik

Biol Blood Marrow Transplant· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Paul G Richardson, Marcie L Riches, Nancy A Kernan, Joel A Brochstein, Shin Mineishi, Bijan Nejadnik

Blood· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Stephen Salloway, Reisa Sperling, Nick C Fox, Kaj Blennow, William Klunk, Bijan Nejadnik

N Engl J Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource utilization before and during infliximab therapy in patients with inflammatory bowel disease.
Heidi C Waters, Julie E Vanderpoel, Bijan Nejadnik, R Scott McKenzie, Orsolya E Lunacsek

J Med Econ· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory analysis of healthcare costs and utilization of pediatric patients with Crohn's disease.
Heidi C Waters, Rhadjena P Hilliard, Elton Teng, Mirza I Rahman, Ron Ferrer, Bijan Nejadnik

Dig Dis Sci· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis